Missouri Technology Corporation — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Aptimmune Biologicsaptimmune.com𝕏Jun 2017✓ verified
Aptimmune develops vaccines for swine health, partnering with vaccine development and swine health consulting companies to speed product development, testing and manufacturing.
AgTechBiotechHealthtechChampaign, US
Aaron Gilbertie(CEO)Federico Zuckermann(Executive Officer, Director)
BoardRobert Easter(Director)Paul Olivo(Director)Gary Durack(Director)
Co-investorsArsenalCultivation CapitalThe Yield LabIllinois VenturesThe Yield Lab Asia Pacific
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.